Investigational Drug Case Report Form (Data Collection Form) Template

Using the template below, items to be documented on the case report form can be modified, added or omitted based on the data to be collected as specified in the actual study protocol.

Identifier (Must be included on every page)

Subject identifier

Study identifier

Visit type

Visit date

Investigator signature and date

Subject Enrollment Form(Data must be relevant to the study protocol)

Date of birth

Gender

Race

Weight & height

Subject number

Date informed consent signed

Date subject started the study

Eligibility Form

Inclusion criteria list – all answers must be YES

Exclusion criteria list – all answers must be NO

Subject Randomization Form

Date subject randomized

Subject randomization code

Medical History(Data must be relevant to the study protocol)

Medical history of the subject

Physical Examination(Data must be relevant to the study protocol)

Vital signs

Body systems

Clinical Laboratory Data(Those elements defined in the study protocol)

Prior

Baseline

During

End

After

Compliance

Pill count at each protocol interval

Concomitant Medication

Document all subjects’ medications taken during the study at each protocol interval

Adverse Events

Document ALL adverse events during the study including any run-in and follow-up periods

Date reported

Date of onset

Date ended

Severity

Description of adverse event

Event recovery status – resolved, not resolved, continuing

Relationship to study drug

Serious Adverse Events

Document ALL serious adverse events during the study including any run-in and follow-up periods

Date reported

Date of onset

Date ended

Description of serious adverse event

Event recovery status – resolved, not resolved, continuing

Relationship to study drug

Off Study Form

Document subject completion, removal from or drop-out from the study

Date

Reason

Death Report Form

Document ALL deaths during the study including any run-in and follow-up periods

Date

Description of cause of death

Relationship to study drug

Other Information or Data as Required in the Study Protocol